Amarin pushes back sales team ramp-up as Vascepa label decision nears

 

Amarin pushes back sales team ramp-up as Vascepa label decision nears

Vascepa’s initial FDA approval date was set for late September, but now a decision from the FDA is expected Dec. 28, significantly pushing back Amarin’s sales expansion and launch plans. Thermo Fisher …

More Amarin pushes back sales team ramp-up as Vascepa label decision nears Videos

Leave a Reply